183 related articles for article (PubMed ID: 28436749)
1. Differential diagnosis of neonatal alloimmune thrombocytopenia: Type 2B von Willebrand disease.
Penel-Page M; Meunier S; Fretigny M; Le Quellec S; Boisseau P; Vinciguerra C; Ternisien C; Rugeri L
Platelets; 2017 Dec; 28(8):825-828. PubMed ID: 28436749
[TBL] [Abstract][Full Text] [Related]
2. Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia.
Kranzhöfer D; Pavlova A; Schneider H; Franck P; Glonnegger H; Büchsel M; Yoshimi-Nöllke A; Oldenburg J; Zieger B
Hamostaseologie; 2021 Dec; 41(6):469-474. PubMed ID: 34942660
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
[TBL] [Abstract][Full Text] [Related]
4. Type 2B von Willebrand Disease: An Unusual Cause of Severe Neonatal Thrombocytopenia.
Rotz SJ; Palumbo JS; Ware RE
J Pediatr Hematol Oncol; 2017 Aug; 39(6):473-475. PubMed ID: 28060120
[TBL] [Abstract][Full Text] [Related]
5. A family having type 2B von Willebrand disease with a novel VWF p.R1308S mutation: Detection of characteristic platelet aggregates on peripheral blood smears as the key aspect of diagnosis.
Hatta K; Kunishima S; Suganuma H; Tanaka N; Ohkawa N; Shimizu T
Thromb Res; 2015 Oct; 136(4):813-7. PubMed ID: 26278967
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation.
Woods AI; Kempfer AC; Paiva J; Sanchez-Luceros A; Bermejo E; Chuit R; Alberto MF; Blanco AN; Lazzari MA
Semin Thromb Hemost; 2017 Feb; 43(1):92-100. PubMed ID: 27978591
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
8. Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmas.
Scepansky E; Othman M; Smith H
Acta Haematol; 2014; 131(4):213-7. PubMed ID: 24296552
[TBL] [Abstract][Full Text] [Related]
9. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
[TBL] [Abstract][Full Text] [Related]
10. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.
Castaman G; Federici AB
Semin Thromb Hemost; 2016 Jul; 42(5):478-82. PubMed ID: 27148840
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
[TBL] [Abstract][Full Text] [Related]
12. A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers.
Ozeki M; Kunishima S; Kasahara K; Funato M; Teramoto T; Kaneko H; Fukao T; Kondo N
Thromb Res; 2010 Feb; 125(2):e17-22. PubMed ID: 19740526
[TBL] [Abstract][Full Text] [Related]
13. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
[TBL] [Abstract][Full Text] [Related]
14. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease.
Jilma-Stohlawetz P; Knöbl P; Gilbert JC; Jilma B
Thromb Haemost; 2012 Aug; 108(2):284-90. PubMed ID: 22740102
[TBL] [Abstract][Full Text] [Related]
15. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.
Jilma B; Paulinska P; Jilma-Stohlawetz P; Gilbert JC; Hutabarat R; Knöbl P
Thromb Haemost; 2010 Sep; 104(3):563-70. PubMed ID: 20589313
[TBL] [Abstract][Full Text] [Related]
16. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
17. A thrombopoietin receptor agonist to rescue an unusual platelet transfusion-induced reaction in a p.V1316M-associated von Willebrand disease type 2B patient.
Casari C; Favier R; Legendre P; Kauskot A; Adam F; Picard V; Lenting PT; Denis CV; Proulle V
Ther Adv Hematol; 2022; 13():20406207221076812. PubMed ID: 35186246
[TBL] [Abstract][Full Text] [Related]
18. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
[TBL] [Abstract][Full Text] [Related]
19. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
[TBL] [Abstract][Full Text] [Related]
20. Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence.
Dupont A; Soukaseum C; Cheptou M; Adam F; Nipoti T; Lourenco-Rodrigues MD; Legendre P; Proulle V; Rauch A; Kawecki C; Bryckaert M; Rosa JP; Paris C; Ternisien C; Boisseau P; Goudemand J; Borgel D; Lasne D; Maurice P; Lenting PJ; Denis CV; Susen S; Kauskot A
Haematologica; 2019 Dec; 104(12):2493-2500. PubMed ID: 30819911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
